B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Proscillaridin

219 PubMed studies analyzed · 3 RCTs · Evidence Score: 42.5

Research Domains

Proscillaridin has been studied across 18 research domains including ❤️ Cardiovascular, 🔬 Oncology, ⚡ Energy & Fatigue, 🫘 Kidney, 🫁 Respiratory. The primary research focus is ❤️ Cardiovascular with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Proscillaridin is generated deterministically from 219 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.